• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Generalizability of kidney transplant data in electronic health records - The Epic Cosmos database vs the Scientific Registry of Transplant Recipients.电子健康记录中肾移植数据的可推广性——Epic Cosmos数据库与移植受者科学登记处的比较
Am J Transplant. 2025 Apr;25(4):744-755. doi: 10.1016/j.ajt.2024.11.008. Epub 2024 Nov 15.
2
Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)-Infected Recipients.人类免疫缺陷病毒(HIV)感染受者肾再次移植后的死亡率增加及移植物丢失
Am J Transplant. 2017 Jan;17(1):173-179. doi: 10.1111/ajt.13922. Epub 2016 Jul 19.
3
Kidney transplant outcomes in recipients with visual, hearing, physical and walking impairments: a prospective cohort study.视觉、听觉、身体和行走障碍受者的肾脏移植结局:一项前瞻性队列研究。
Nephrol Dial Transplant. 2020 Jul 1;35(7):1262-1270. doi: 10.1093/ndt/gfz164.
4
Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes.肾移植前后的处方阿片类药物使用:对移植后结局的影响。
Am J Transplant. 2018 Dec;18(12):2987-2999. doi: 10.1111/ajt.14714. Epub 2018 Apr 17.
5
Impact of Protease Inhibitor-Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients.基于蛋白酶抑制剂的抗逆转录病毒疗法对 HIV+肾移植受者结局的影响。
Am J Transplant. 2017 Dec;17(12):3114-3122. doi: 10.1111/ajt.14419. Epub 2017 Aug 24.
6
Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data.肾移植后第一年使用二甲双胍、相关因素及其与糖尿病移植受者相关结局的关系:整合登记和药房理赔数据的回顾性分析。
Clin Transplant. 2018 Aug;32(8):e13302. doi: 10.1111/ctr.13302. Epub 2018 Jun 29.
7
Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.直接作用抗病毒治疗时代前后 HIV/HCV 合并感染肾移植受者的临床结局:10 年单中心经验。
Clin Transplant. 2019 May;33(5):e13532. doi: 10.1111/ctr.13532. Epub 2019 Apr 4.
8
Early Hospital Readmission in Older and Younger Kidney Transplant Recipients.老年和年轻肾移植受者的早期医院再入院。
Am J Nephrol. 2018;48(4):235-241. doi: 10.1159/000492338. Epub 2018 Sep 18.
9
Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.拒绝什么?与降低增加的传染性风险肾脏相关的患者结果。
Am J Transplant. 2018 Mar;18(3):617-624. doi: 10.1111/ajt.14577. Epub 2017 Dec 5.
10
Graft survival of fourth-time renal transplant recipients is similar to third-time recipients: A SRTR database analysis.第四次肾移植受者的移植物存活率与第三次受者相似:SRTR 数据库分析。
Clin Transplant. 2020 Jul;34(7):e13884. doi: 10.1111/ctr.13884. Epub 2020 May 10.

引用本文的文献

1
Finding actionable information in the universe of data.在海量数据中寻找可付诸行动的信息。
Am J Transplant. 2025 Apr;25(4):648-649. doi: 10.1016/j.ajt.2025.01.004. Epub 2025 Jan 16.

本文引用的文献

1
Common definitions and variables are needed for the United States to join the conversation on acute-on-chronic liver failure.美国需要共同定义和变量,以便参与到慢性加急性肝衰竭的讨论中。
Am J Transplant. 2024 Oct;24(10):1755-1760. doi: 10.1016/j.ajt.2024.06.021. Epub 2024 Jul 6.
2
HL7 Fast Healthcare Interoperability Resources (HL7 FHIR) in digital healthcare ecosystems for chronic disease management: Scoping review.HL7 快速医疗互操作性资源 (HL7 FHIR) 在慢性病管理的数字医疗生态系统中的应用:范围综述。
Int J Med Inform. 2024 Sep;189:105507. doi: 10.1016/j.ijmedinf.2024.105507. Epub 2024 Jun 4.
3
New Tools for Data Harmonization and Their Potential Applications in Organ Transplantation.数据协调的新工具及其在器官移植中的潜在应用。
Transplantation. 2024 Dec 1;108(12):2306-2317. doi: 10.1097/TP.0000000000005048. Epub 2024 May 17.
4
Is it Time to Abandon the Use of -Values in Early Phase Translational Trials: Why (Effect) Size Matters.是时候在早期转化试验中摒弃使用P值了:为何(效应)大小至关重要。
JACC Basic Transl Sci. 2024 Feb 26;9(2):278-279. doi: 10.1016/j.jacbts.2024.01.008. eCollection 2024 Feb.
5
Augmenting the Unites States transplant registry with external mortality data: A moving target ripe for further improvement.利用外部死亡率数据扩充美国移植登记系统:一个有待进一步改进的不断变化的目标。
Am J Transplant. 2024 Feb;24(2):190-212. doi: 10.1016/j.ajt.2023.09.002. Epub 2023 Sep 12.
6
Predicting post-liver transplant outcomes in patients with acute-on-chronic liver failure using Expert-Augmented Machine Learning.使用专家增强机器学习预测慢加急性肝衰竭患者肝移植术后结局。
Am J Transplant. 2023 Dec;23(12):1908-1921. doi: 10.1016/j.ajt.2023.08.022. Epub 2023 Aug 30.
7
Discrepant Outcomes between National Kidney Transplant Data Registries in the United States.美国国家肾脏移植数据登记处之间的结果差异。
J Am Soc Nephrol. 2023 Nov 1;34(11):1863-1874. doi: 10.1681/ASN.0000000000000194. Epub 2023 Aug 3.
8
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.美国 JYNNEOS 疫苗对猴痘疾病的有效性。
N Engl J Med. 2023 Jun 29;388(26):2434-2443. doi: 10.1056/NEJMoa2215201. Epub 2023 May 18.
9
Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population.激素替代疗法与实体器官移植受者 COVID-19 结局与普通人群的比较。
Am J Transplant. 2023 Jul;23(7):1035-1047. doi: 10.1016/j.ajt.2023.04.020. Epub 2023 Apr 26.
10
Trends and opportunities in computable clinical phenotyping: A scoping review.可计算临床表型分析的趋势与机遇:一项范围综述
J Biomed Inform. 2023 Apr;140:104335. doi: 10.1016/j.jbi.2023.104335. Epub 2023 Mar 16.

电子健康记录中肾移植数据的可推广性——Epic Cosmos数据库与移植受者科学登记处的比较

Generalizability of kidney transplant data in electronic health records - The Epic Cosmos database vs the Scientific Registry of Transplant Recipients.

作者信息

Mankowski Michal A, Bae Sunjae, Strauss Alexandra T, Lonze Bonnie E, Orandi Babak J, Stewart Darren, Massie Allan B, McAdams-DeMarco Mara A, Oermann Eric K, Habal Marlena, Iturrate Eduardo, Gentry Sommer E, Segev Dorry L, Axelrod David

机构信息

Department of Surgery, NYU Grossman School of Medicine, New York, New York, USA.

Department of Surgery, NYU Grossman School of Medicine, New York, New York, USA; Department of Population Health, NYU Grossman School of Medicine, New York, New York, USA.

出版信息

Am J Transplant. 2025 Apr;25(4):744-755. doi: 10.1016/j.ajt.2024.11.008. Epub 2024 Nov 15.

DOI:10.1016/j.ajt.2024.11.008
PMID:39550008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11972892/
Abstract

Developing real-world evidence from electronic health records (EHR) is vital to advancing kidney transplantation (KT). We assessed the feasibility of studying KT using the Epic Cosmos aggregated EHR data set, which includes 274 million unique individuals cared for in 238 US health systems, by comparing it with the Scientific Registry of Transplant Recipients (SRTR). We identified 69 418 KT recipients who underwent transplants between January 2014 and December 2022 in Cosmos (39.4% of all US KT transplants during this period). The demographics and clinical characteristics of recipients captured in Cosmos were consistent with the overall SRTR cohort. Survival estimates were generally comparable, although there were some differences in long-term survival. At 7 years posttransplant, patient survival was 80.4% in Cosmos and 77.8% in SRTR. Multivariable Cox regression showed consistent associations between clinical factors and mortality in both cohorts, with minor discrepancies in the associations between death and both age and race. In summary, Cosmos provides a reliable platform for KT research, allowing EHR-level clinical granularity not available with either the transplant registry or health care claims. Consequently, Cosmos will enable novel analyses to improve our understanding of KT management on a national scale.

摘要

从电子健康记录(EHR)中生成真实世界证据对于推进肾移植(KT)至关重要。我们通过将Epic Cosmos汇总的EHR数据集与移植受者科学注册系统(SRTR)进行比较,评估了使用该数据集研究KT的可行性。Epic Cosmos数据集包含在美国238个医疗系统中接受治疗的2.74亿独特个体。我们确定了2014年1月至2022年12月期间在Cosmos中接受移植的69418名KT受者(占该时期美国所有KT移植的39.4%)。Cosmos中记录的受者人口统计学和临床特征与整个SRTR队列一致。生存估计总体上具有可比性,尽管长期生存存在一些差异。移植后7年,Cosmos中的患者生存率为80.4%,SRTR中的为77.8%。多变量Cox回归显示,两个队列中临床因素与死亡率之间的关联一致,死亡与年龄和种族之间的关联存在细微差异。总之,Cosmos为KT研究提供了一个可靠的平台,允许进行移植登记或医疗保健索赔无法提供的EHR级临床粒度分析。因此,Cosmos将能够进行新颖的分析,以提高我们在全国范围内对KT管理的理解。